Amgen's earnings call highlighted strong financial performance in 2012 and a positive outlook for 2013.  Management emphasized share repurchases, dividend increases, and acquisitions, suggesting a commitment to shareholder returns.  Guidance for 2013 projects modest revenue and earnings growth, but the focus on long-term strategies and pipeline development—including the deCODE acquisition—indicates the company's confidence in future growth.

[1]
